{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,20]],"date-time":"2026-09-20T17:39:37Z","timestamp":1789925977557,"version":"4.0.1"},"reference-count":18,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2020,1,6]],"date-time":"2020-01-06T00:00:00Z","timestamp":1578268800000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"},{"start":{"date-parts":[[2020,1,6]],"date-time":"2020-01-06T00:00:00Z","timestamp":1578268800000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["BMC Infect Dis"],"published-print":{"date-parts":[[2020,12]]},"abstract":"<jats:title>Abstract<\/jats:title><jats:sec><jats:title>Background<\/jats:title><jats:p>The development of respiratory infections secondary to<jats:italic>Aspergillus spp.<\/jats:italic>spores found ubiquitously in the ambient environment is uncommon in immunocompetent patients. Previous reports of invasive upper airway aspergillosis in immunocompetent patients have generally demonstrated the efficacy of treatment regimens utilizing antifungal agents in combination with periodic endoscopic debridement, with symptoms typically resolving within months of initiating therapy.<\/jats:p><\/jats:sec><jats:sec><jats:title>Case presentation<\/jats:title><jats:p>A 43-year-old previously healthy female presented with worsening respiratory symptoms after failing to respond to long-term antibiotic treatment of bacterial sinusitis. Biopsy of her nasopharynx and trachea revealed extensive fungal infiltration and<jats:italic>Aspergillus fumigatus<\/jats:italic>was isolated on tissue culture. Several months of oral voriconazole monotherapy failed to resolve her symptoms and she underwent mechanical debridement for symptom control. Following transient improvement, her symptoms subsequently returned and failed to fully resolve in spite of increased voriconazole dosing and multiple additional tissue debridements over the course of many years.<\/jats:p><\/jats:sec><jats:sec><jats:title>Conclusions<\/jats:title><jats:p>Invasive upper airway aspergillosis is exceedingly uncommon in immunocompetent patients. In the rare instances that such infections do occur, combinatorial voriconazole and endoscopic debridement is typically an efficacious treatment approach. However, some patients may continue to experience refractory symptoms. In such cases, continued aggressive treatment may potentially slow disease progression even if complete disease resolution cannot be achieved.<\/jats:p><\/jats:sec>","DOI":"10.1186\/s12879-019-4744-2","type":"journal-article","created":{"date-parts":[[2020,1,6]],"date-time":"2020-01-06T16:02:43Z","timestamp":1578326563000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":4,"title":["Invasive pseudomembranous upper airway and tracheal Aspergillosis refractory to systemic antifungal therapy and serial surgical debridement in an Immunocompetent patient"],"prefix":"10.1186","volume":"20","author":[{"given":"Shihan N.","family":"Khan","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rashmi","family":"Manur","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"John S.","family":"Brooks","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Michael A.","family":"Husson","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kevin","family":"Leahy","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Matthew","family":"Grant","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2020,1,6]]},"reference":[{"issue":"2","key":"4744_CR1","doi-asserted-by":"publisher","first-page":"249","DOI":"10.1016\/0002-9343(86)90259-7","volume":"81","author":"VL Yu","year":"1986","unstructured":"Yu VL, Muder RR, Poorsattar A. Significance of isolation of Aspergillus from the respiratory tract in diagnosis of invasive pulmonary aspergillosis. Results from a three-year prospective study. Am J Med. 1986;81(2):249\u201354.","journal-title":"Am J Med"},{"issue":"6","key":"4744_CR2","doi-asserted-by":"publisher","first-page":"689","DOI":"10.1111\/j.1469-0691.2009.02923.x","volume":"16","author":"N Wu","year":"2010","unstructured":"Wu N, Huang Y, Li Q, Bai C, Huang HD, Yao XP. Isolated invasive Aspergillus tracheobronchitis: a clinical study of 19 cases. Clin Microbiol Infect. 2010;16(6):689\u201395.","journal-title":"Clin Microbiol Infect"},{"key":"4744_CR3","doi-asserted-by":"publisher","first-page":"2310","DOI":"10.1100\/2011\/865239","volume":"11","author":"R Krenke","year":"2011","unstructured":"Krenke R, Grabczak EM. Tracheobronchial manifestations of Aspergillus infections. ScientificWorldJournal. 2011;11:2310\u201329.","journal-title":"ScientificWorldJournal"},{"issue":"3","key":"4744_CR4","doi-asserted-by":"publisher","first-page":"357","DOI":"10.1093\/clinids\/8.3.357","volume":"8","author":"GH Karam","year":"1986","unstructured":"Karam GH, Griffin FM Jr. Invasive pulmonary aspergillosis in nonimmunocompromised, nonneutropenic hosts. Rev Infect Dis. 1986;8(3):357\u201363.","journal-title":"Rev Infect Dis"},{"issue":"5","key":"4744_CR5","doi-asserted-by":"publisher","first-page":"366","DOI":"10.1097\/MAJ.0b013e318279e3b2","volume":"346","author":"Y Li","year":"2013","unstructured":"Li Y, Yu F, Parsons C, Chen C, Ye M, Ye J, Zhou Y, Cai C. Pseudomembranous Aspergillus tracheobronchitis: a potential for high mortality in low-risk patients. Am J Med Sci. 2013;346(5):366\u201370.","journal-title":"Am J Med Sci"},{"issue":"12","key":"4744_CR6","doi-asserted-by":"publisher","first-page":"1294","DOI":"10.1002\/alr.21828","volume":"6","author":"B D'Anza","year":"2016","unstructured":"D'Anza B, Stokken J, Greene JS, Kennedy T, Woodard TD, Sindwani R. Chronic invasive fungal sinusitis: characterization and shift in management of a rare disease. Int Forum Allergy Rhinol. 2016;6(12):1294\u2013300.","journal-title":"Int Forum Allergy Rhinol"},{"issue":"2","key":"4744_CR7","doi-asserted-by":"publisher","first-page":"107","DOI":"10.1097\/00000441-200502000-00011","volume":"329","author":"A Mohan","year":"2005","unstructured":"Mohan A, Guleria R, Mukhopadhyaya S, Das C, Nayak A, Sharma SK. Invasive tracheobronchial aspergillosis in an immunocompetent person. Am J Med Sci. 2005;329(2):107\u20139.","journal-title":"Am J Med Sci"},{"issue":"9","key":"4744_CR8","doi-asserted-by":"publisher","first-page":"1809","DOI":"10.1002\/lary.20520","volume":"119","author":"A Chakrabarti","year":"2009","unstructured":"Chakrabarti A, et al. Fungal rhinosinusitis: a categorization and definitional schema addressing current controversies. Laryngoscope. 2009;119(9):1809\u201318.","journal-title":"Laryngoscope"},{"issue":"9","key":"4744_CR9","doi-asserted-by":"publisher","first-page":"764","DOI":"10.1016\/j.amjmed.2006.12.013","volume":"120","author":"AE Azar","year":"2007","unstructured":"Azar AE, Ballas ZK. Evaluation of the adult with suspected immunodeficiency. Am J Med. 2007;120(9):764\u20138.","journal-title":"Am J Med"},{"issue":"5","key":"4744_CR10","doi-asserted-by":"publisher","first-page":"1186","DOI":"10.1016\/j.jaci.2015.04.049","volume":"136","author":"FA Bonilla","year":"2015","unstructured":"Bonilla FA, et al. Practice parameter for the diagnosis and management of primary immunodeficiency. J Allergy Clin Immunol. 2015;136(5):1186\u2013205. e1-78.","journal-title":"J Allergy Clin Immunol"},{"issue":"11","key":"4744_CR11","doi-asserted-by":"publisher","first-page":"1047","DOI":"10.1136\/thx.54.11.1047","volume":"54","author":"RJ Boots","year":"1999","unstructured":"Boots RJ, Paterson DL, Allworth AM, Faoagali JL. Successful treatment of post-influenza pseudomembranous necrotising bronchial aspergillosis with liposomal amphotericin, inhaled amphotericin B, gamma interferon and GM-CSF. Thorax. 1999;54(11):1047\u20139.","journal-title":"Thorax"},{"issue":"5","key":"4744_CR12","doi-asserted-by":"publisher","first-page":"323","DOI":"10.4103\/0972-5229.132505","volume":"18","author":"P Nasa","year":"2014","unstructured":"Nasa P, Yadav R, Nagrani SK, Raina S, Gupta A, Jain S. Invasive pulmonary aspergillosis in an immunocompetent patient with severe dengue fever. Indian J Crit Care Med. 2014;18(5):323\u20135.","journal-title":"Indian J Crit Care Med"},{"issue":"1","key":"4744_CR13","doi-asserted-by":"crossref","first-page":"32","DOI":"10.1002\/rcr2.144","volume":"4","author":"H Ohta","year":"2016","unstructured":"Ohta H, Yamazaki S, Miura Y, Kanazawa M, Sakai F, Nagata M. Invasive tracheobronchial aspergillosis progressing from bronchial to diffuse lung parenchymal lesions. Respirol Case Rep. 2016;4(1):32\u20134.","journal-title":"Respirol Case Rep"},{"issue":"6","key":"4744_CR14","doi-asserted-by":"publisher","first-page":"408","DOI":"10.1056\/NEJMoa020191","volume":"347","author":"R Herbrecht","year":"2002","unstructured":"Herbrecht R, et al. Voriconazole versus amphotericin B for primary therapy of invasive aspergillosis. N Engl J Med. 2002;347(6):408\u201315.","journal-title":"N Engl J Med"},{"issue":"4","key":"4744_CR15","doi-asserted-by":"publisher","first-page":"e1","DOI":"10.1093\/cid\/ciw326","volume":"63","author":"TF Patterson","year":"2016","unstructured":"Patterson TF, et al. Practice guidelines for the diagnosis and Management of Aspergillosis: 2016 update by the Infectious Diseases Society of America. Clin Infect Dis. 2016;63(4):e1\u2013e60.","journal-title":"Clin Infect Dis"},{"issue":"2","key":"4744_CR16","doi-asserted-by":"publisher","first-page":"201","DOI":"10.1086\/524669","volume":"46","author":"A Pascual","year":"2008","unstructured":"Pascual A, Calandra T, Bolay S, Buclin T, Bille J, Marchetti O. Voriconazole therapeutic drug monitoring in patients with invasive mycoses improves efficacy and safety outcomes. Clin Infect Dis. 2008;46(2):201\u201311.","journal-title":"Clin Infect Dis"},{"issue":"1","key":"4744_CR17","doi-asserted-by":"publisher","first-page":"125","DOI":"10.1016\/j.jaci.2004.09.037","volume":"115","author":"JU Ponikau","year":"2005","unstructured":"Ponikau JU, Sherris DA, Weaver A, Kita H. Treatment of chronic rhinosinusitis with intranasal amphotericin B: a randomized, placebo-controlled, double-blind pilot trial. J Allergy Clin Immunol. 2005;115(1):125\u201331.","journal-title":"J Allergy Clin Immunol"},{"key":"4744_CR18","first-page":"1","volume":"6","author":"RB Cain","year":"2013","unstructured":"Cain RB, Lal D. Update on the management of chronic rhinosinusitis. Infect Drug Resist. 2013;6:1\u201314.","journal-title":"Infect Drug Resist"}],"container-title":["BMC Infectious Diseases"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1186\/s12879-019-4744-2.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1186\/s12879-019-4744-2\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1186\/s12879-019-4744-2.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,10,10]],"date-time":"2022-10-10T02:47:26Z","timestamp":1665370046000},"score":1,"resource":{"primary":{"URL":"https:\/\/bmcinfectdis.biomedcentral.com\/articles\/10.1186\/s12879-019-4744-2"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2020,1,6]]},"references-count":18,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2020,12]]}},"alternative-id":["4744"],"URL":"https:\/\/doi.org\/10.1186\/s12879-019-4744-2","relation":{},"ISSN":["1471-2334"],"issn-type":[{"value":"1471-2334","type":"electronic"}],"subject":[],"published":{"date-parts":[[2020,1,6]]},"assertion":[{"value":"16 September 2019","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"27 December 2019","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"6 January 2020","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"Not applicable.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"Written informed consent for publication of their clinical details and clinical images was obtained from the patient. A copy of the consent form is available for review by the Editor of this journal.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"<b><i>\\<\/i><\/b>The authors declare that they have no competing interests.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"13"}}